News

This study aims to evaluate the safety and efficacy of (18F)-ML-10 in early assessment of response of metastatic brain tumors to high-dose, single-fraction radiotherapy (also known as stereotactic

The FDA’s approval of Trilipix was based on the largest clinical trial program to date designed to evaluate the efficacy and safety of a fibrate in combination with

Citi said that its wide acceptance and ability to integrate fully with Schering-Plough’s internal payment and expense management systems will enable Schering-Plough to streamline its corporate, purchasing and

As chief marketing officer (CMO), Mr Blumenfield has overall responsibility for Prime’s marketing strategy, product development and other market-related initiatives. He will focus on continuing Prime’s expansion and

As a consequence, Alchemia will receive payments totaling $1.62 million from Dr Reddy’s, its manufacturing and marketing partner. Approximately $1 million will be received in December 2008 and

Dr Contag founded Cobalt Technologies in 2006 and served as CEO. Prior to starting Cobalt, Dr Contag founded Xenogen, a biotechnology company. Dr Contag received her PhD in

Study 304 successfully met its primary endpoint of a statistically significant reduction in summed pain intensity differences from baseline over 24 hours (SPID24) for Acetavance 1000mg compared to

The interim analysis conducted by the Data Safety Monitoring Board (DSMB) evaluated stroke patients’ outcome 90 days following an acute ischemic stroke, comparing treatment with Viprinex to treatment

In the proposed trial Hemopure would be studied for use in the treatment of anemia secondary to induction chemotherapy in patients with acute myeloid leukemia (AML) who refuse